1. Home
  2. OGS vs RGEN Comparison

OGS vs RGEN Comparison

Compare OGS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ONE Gas Inc.

OGS

ONE Gas Inc.

HOLD

Current Price

$78.40

Market Cap

5.5B

Sector

Utilities

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$122.31

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGS
RGEN
Founded
1906
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.6B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
OGS
RGEN
Price
$78.40
$122.31
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$89.00
$167.67
AVG Volume (30 Days)
564.3K
1.2M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
3.10%
N/A
EPS Growth
11.76
286.96
EPS
2.04
0.15
Revenue
$2,578,005,000.00
$141,236,000.00
Revenue This Year
$12.51
$14.30
Revenue Next Year
N/A
$14.52
P/E Ratio
$37.89
$844.20
Revenue Growth
42.54
35.10
52 Week Low
$70.87
$100.99
52 Week High
$90.78
$175.77

Technical Indicators

Market Signals
Indicator
OGS
RGEN
Relative Strength Index (RSI) 36.68 54.31
Support Level $76.95 $121.25
Resistance Level $79.23 $131.53
Average True Range (ATR) 1.52 5.91
MACD -0.29 1.46
Stochastic Oscillator 33.50 74.44

Price Performance

Historical Comparison
OGS
RGEN

About OGS ONE Gas Inc.

ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. It operates in one reportable business segment: regulated public utilities that deliver natural gas to residential, commercial, and transportation customers.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: